Human recombinant erythropoietin: progress in clinical development.
Kubiak
W
W
Biuro Informacji Technicznej CILAG, Poznań.
Karwacki
M
M
Mazur
I
I
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000740:Anemia / Q000209:etiology* / Q000628:therapy*; D001172:Arthritis, Rheumatoid / Q000150:complications; D001327:Autoimmune Diseases / Q000150:complications; D001782:Blood Donors; D004921:Erythropoietin / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000150:complications; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D009369:Neoplasms / Q000150:complications; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin